tiprankstipranks
Concord Biotech Ltd. (IN:CONCORDBIO)
:CONCORDBIO
India Market
CONCORDBIO
Concord Biotech Ltd.
RESEARCH TOOLSreports

Concord Biotech Ltd. (CONCORDBIO) Ratios

2 Followers

Concord Biotech Ltd. Ratios

IN:CONCORDBIO's free cash flow for Q2 2026 was ₹0.80. For the 2026 fiscal year, IN:CONCORDBIO's free cash flow was decreased by ₹ and operating cash flow was ₹0.35. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 6.97 6.17 6.30 3.79 4.08
Quick Ratio
 5.18 4.87 4.84 2.69 2.82
Cash Ratio
 0.11 <0.01 0.11 0.02 <0.01
Solvency Ratio
 1.91 1.92 2.07 1.31 1.07
Operating Cash Flow Ratio
 0.97 1.34 1.87 1.28 1.34
Short-Term Operating Cash Flow Coverage
 0.00 649.20 42.61 9.84 7.07
Net Current Asset Value
₹ 8.83B₹ 9.14B₹ 7.22B₹ 5.04B₹ 4.23B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 0.02 0.05
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 0.02 0.06
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.02 0.05
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 <0.01 0.03
Financial Leverage Ratio
 1.11 1.12 1.11 1.17 1.19
Debt Service Coverage Ratio
 1.20K 273.97 35.71 7.93 6.07
Interest Coverage Ratio
 1.47K 577.89 166.74 56.71 67.85
Debt to Market Cap
 0.00 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.18 0.38 1.23 3.89 6.56
Net Debt to EBITDA
 -0.03 <0.01 -0.01 0.08 0.22
Profitability Margins
Gross Profit Margin
60.72%64.03%65.61%77.49%75.89%
EBIT Margin
33.96%38.34%38.03%35.15%32.12%
EBITDA Margin
39.48%42.72%43.13%41.33%38.97%
Operating Profit Margin
37.41%50.16%51.26%60.71%58.38%
Pretax Profit Margin
35.74%41.21%40.57%37.74%33.32%
Net Profit Margin
26.93%30.97%30.30%28.14%24.54%
Continuous Operations Profit Margin
26.85%30.97%30.30%28.14%24.54%
Net Income Per EBT
75.34%75.15%74.68%74.56%73.65%
EBT Per EBIT
95.53%82.15%79.15%62.17%57.06%
Return on Assets (ROA)
15.42%18.27%18.12%15.86%13.33%
Return on Equity (ROE)
17.72%20.50%20.18%18.61%15.86%
Return on Capital Employed (ROCE)
23.20%32.54%33.44%39.18%35.96%
Return on Invested Capital (ROIC)
17.42%24.42%24.85%28.66%25.79%
Return on Tangible Assets
15.44%18.28%18.12%15.86%13.36%
Earnings Yield
2.90%2.14%1.98%2.43%1.77%
Efficiency Ratios
Receivables Turnover
 2.92 2.30 2.91 2.73 2.75
Payables Turnover
 5.26 3.82 3.70 2.05 2.07
Inventory Turnover
 1.65 1.80 1.68 0.90 0.88
Fixed Asset Turnover
 1.34 1.42 1.29 1.11 1.11
Asset Turnover
 0.57 0.59 0.60 0.56 0.54
Working Capital Turnover Ratio
 2.51 1.41 1.58 1.68 1.46
Cash Conversion Cycle
 277.13 265.71 243.95 359.08 370.68
Days of Sales Outstanding
 124.99 158.66 125.48 133.87 132.87
Days of Inventory Outstanding
 221.57 202.63 217.02 403.45 414.25
Days of Payables Outstanding
 69.44 95.57 98.55 178.24 176.44
Operating Cycle
 346.57 361.28 342.50 537.32 547.12
Cash Flow Ratios
Operating Cash Flow Per Share
 14.44 23.65 25.38 23.51 19.83
Free Cash Flow Per Share
 9.33 13.02 17.18 9.65 4.97
CapEx Per Share
 5.11 10.63 8.19 13.87 14.86
Free Cash Flow to Operating Cash Flow
 0.65 0.55 0.68 0.41 0.25
Dividend Paid and CapEx Coverage Ratio
 0.91 1.22 1.69 1.24 0.92
Capital Expenditure Coverage Ratio
 2.82 2.23 3.10 1.70 1.33
Operating Cash Flow Coverage Ratio
 94.04 83.32 27.26 7.80 3.32
Operating Cash Flow to Sales Ratio
 0.13 0.21 0.26 0.29 0.29
Free Cash Flow Yield
0.91%0.78%1.15%1.02%0.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 34.37 46.81 50.53 41.08 56.38
Price-to-Sales (P/S) Ratio
 9.25 14.50 15.31 11.56 13.83
Price-to-Book (P/B) Ratio
 5.87 9.60 10.20 7.65 8.94
Price-to-Free Cash Flow (P/FCF) Ratio
 109.88 127.69 86.60 97.74 189.79
Price-to-Operating Cash Flow Ratio
 70.97 70.31 58.65 40.09 47.54
Price-to-Earnings Growth (PEG) Ratio
 -9.66 2.27 1.78 1.10 -2.21
Price-to-Fair Value
 5.87 9.60 10.20 7.65 8.94
Enterprise Value Multiple
 23.41 33.93 35.49 28.05 35.72
Enterprise Value
 107.57B 173.98B 155.63B 98.91B 99.25B
EV to EBITDA
 23.52 33.93 35.49 28.05 35.72
EV to Sales
 9.28 14.50 15.30 11.59 13.92
EV to Free Cash Flow
 110.23 127.71 86.57 98.01 190.98
EV to Operating Cash Flow
 71.20 70.32 58.63 40.21 47.84
Tangible Book Value Per Share
 174.43 173.17 145.90 123.29 105.11
Shareholders’ Equity Per Share
 174.68 173.27 145.93 123.31 105.45
Tax and Other Ratios
Effective Tax Rate
 0.25 0.25 0.25 0.25 0.26
Revenue Per Share
 110.76 114.71 97.21 81.55 68.15
Net Income Per Share
 29.82 35.52 29.45 22.95 16.72
Tax Burden
 0.75 0.75 0.75 0.75 0.74
Interest Burden
 1.05 1.07 1.07 1.07 1.04
Research & Development to Revenue
 0.02 0.02 0.02 0.04 0.04
SG&A to Revenue
 0.10 0.12 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.41 0.67 0.86 1.02 1.19
Currency in INR